Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Denmark

Marie Skłodowska-Curie Action · Running

DrugMOF Disordered Metal-Organic Frameworks for Drug Delivery

Coordinator
Aalborg Universitet, Denmark
Runs
1 September 2023 to 31 August 2025
Status
Running
EU funding
€231k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101107884

What the project is doing

In the project's own words, from its summary on CORDIS.

Drug delivery systems are often needed for delivering drugs in a targeted organ or tissue at a desired concentration range and without toxic side effects. Metal-organic frameworks (MOFs) have emerged as promising drug delivery systems due to their high loading capacity, but currently this is also their main limitation as it results in too rapid drug release in the human body, causing an excessive response and potentially toxic side effects.

Slowing down the drug release rate, while maintaining high loading capacity and biocompatibility, would enable applications within especially cancer therapy. Disordered MOFs (i.e., MOFs without an ordered crystalline structure) have smaller pores and more torturous pathways for drug release. The projects proposed strategy is to load anti-cancer drugs in the crystalline MOF with high surface area and thus high loading capacity and then subsequently subject this material to an order-to-disorder transition, giving rise to slower drug release.

This transition can be induced by either mechanical ball milling or thermal melt-quenching. Molecular dynamics and classification-based machine learning will be used to identify which local atomic structures are best correlated with drug release rate in disordered MOFs. Experimental validation will be performed to establish design principles for MOF structures with a tailored drug release profile. The project builds on complementary expertise of the fellow applicant (disordered biomaterials, in vitro studies) and supervisor (MOFs, simulations, machine learning).

Combined with the research and training environment offered by the host organization (Aalborg University, Denmark), this will ensure the achievement of this novel project as well as the dissemination and exploitation of the results. The goal is to develop principles for designing disordered MOFs for drug delivery. The fellow applicant will emerge from the project with new skills, and the capability to launch his own research group.

Topics

Who is involved

OrganisationCityCountryRole
Aalborg UniversitetAalborgDenmarkCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI